ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 116 filers reported holding ACCELERON PHARMA INC in Q2 2015. The put-call ratio across all filers is 1.90 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $291,000 | -81.7% | 6,000 | -87.2% | 0.02% | -73.8% |
| Q2 2016 | $1,593,000 | -5.9% | 46,863 | -12.4% | 0.06% | +85.7% |
| Q2 2015 | $1,693,000 | -25.9% | 53,500 | -10.8% | 0.04% | -25.5% |
| Q1 2015 | $2,284,000 | -41.1% | 60,000 | -39.8% | 0.05% | -28.8% |
| Q4 2014 | $3,880,000 | – | 99,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |